In muscle, fat accumulation interferes with insulin-stimulated GLUT4 translocation, and in the liver, non-alcoholic fatty liver (NAFL) is associated with hepatic insulin resistance and enhanced production of VLDL-TG that contributes to the development of atherogenic/diabetic dyslipidaemia [24,25]. Here, SLC2A4 is linked to non-alcoholic fatty liver.